The interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from 2017, at a CAGR of 7.5%. USD 14.52 billion. Objectives of interventional cardiology devices market study is to define scope of market, geography which covered global currency and industry limitations and all stakeholders.
Access Sample of Interventional Cardiology Devices Market spread across 173 Pages, Profiling 10 Companies and Supported with 149 Tables and Figuers of 39 is now available at www.reportsnreports.com/contacts/r…aspx?name=1249318 .
Geographically, the interventional cardiology devices market is dominated by North America, followed by Europe in 2017. Asia Pacific is estimated to grow at the fastest rate, due to infrastructural development in its healthcare systems, the rising burden of CVD, and increasing healthcare expenditure in APAC countries.
Target Audience for this Report:
- Manufacturers and vendors of interventional cardiology devices
- Research associations related to non-communicable diseases
- Various research and consulting firms
- Distributors of interventional cardiology devices
- Contract research manufacturers of interventional cardiology devices
- Healthcare institutions
- Research institutes
Global interventional cardiology devices market is segmented based on type and region.
By type, interventional cardiology devices market is segmented into angioplasty balloons, angioplasty stents, catheters, plaque modification devices, hemodynamic flow alteration devices, & other devices. Angioplasty stents segment is estimated to account for largest market of global interventional cardiology devices market in 2017.
Report analyses interventional cardiology devices market by type and region. Apart from a comprehensive geographic product analysis & market sizing, report also provides a competitive landscape that covers growth strategies adopted by industry players over last three years.
In addition, company profiles include product portfolios, developments.
Angioplasty Stents Market, By Type
2 Angioplasty Stents, By Type
3 Drug-Eluting Stents
4 Bare-Metal Stents
5 Bioabsorbable Stents
6 Angioplasty Stents, By Delivery Platform
7 Self-Expanding Stents
8 Balloon-Expandable Stents
The key players in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany).
Key Benefits of Buying the Report:
Other interventional cardiology devices market segmented into guidewires, vascular closure devices, introducer sheaths, & balloon inflation devices. Guidewires segment is estimated to account for largest share of other interventional cardiology devices market.
Growth in number of interventional procedures & increasing use of guidewires in stenting procedures are major factors driving growth of this segment.
The angioplasty stents market is segmented drug-eluting stents, bare-metal stents, and bioresorbable stents. The bioresorbable stents segment is the fastest-growing segment of the global angioplasty stents market.
Technological advancement in stents is driving the growth of this segment.